Rh. Chou et al., TOXICITIES OF TOTAL-BODY IRRADIATION FOR PEDIATRIC BONE-MARROW TRANSPLANTATION, International journal of radiation oncology, biology, physics, 34(4), 1996, pp. 843-851
Citations number
45
Categorie Soggetti
Oncology,"Radiology,Nuclear Medicine & Medical Imaging
Purpose: To determine the acute and tate effects, including cognitive
function, of total body irradiation (TBI) and chemotherapy for bone ma
rrow transplant (BMT) in children with immunodeficiency or hematologic
disorders. Methods and Materials: At UCSF, 15 children with immunodef
iciency disorders and 58 children with leukemia received chemoradiothe
rapy between July 1982 and November 1993 and were evaluated for toxici
ty. Patients with severe combined immunodeficiency disorder (SCID) rec
eived 7 Gy TBI while leukemia patients received 12 Gy TBI. Results: Ei
ght immunodeficient patients (53%) are alive at 4 months to 11 years p
osttransplant. Acute toxicity was limited and treatment well tolerated
. Most patients developed mild nausea and vomiting, skin rash, or eryt
hema. Transient fever/chills, oral mucositis, and alopecia were noted
in approximately 50% of patients. Seventy-three percent of patients de
monstrated acute liver dysfunction, but only four (27%) developed veno
-occlusive disease. All children had decreased growth velocity but nor
mal growth hormone levels. Other endocrinologic evaluations including
adrenocorticotropic hormone (ACTH), cortisol, and thyroid hormones wer
e normal. Only one evaluable girl had delayed puberty with late onset
of secondary sexual characteristics. Neuropsychological testing demons
trated an intelligence quotient (IQ) reduction between the baseline an
d 1 year post-BMT, with some recovery at 3 years. Only one patient dev
eloped a clinically significant cataract. Thirteen percent of patients
had chronic interstitial lung disease. Four children developed exosto
sis. Only 1 of the 15 children developed a second malignancy (acute my
elogenous leukemia) at age 5, 51 months posttransplant for SCID. For p
atients with leukemia, similar toxicities were observed, Twenty-nine p
ercent disease-free survival was noted with a mean follow-up of 4.7 ye
ars. Twenty-two percent had chronic interstitial lung disease and two
patients were diagnosed with cataracts. Graft-vs.-host-disease (GVHD),
pubertal developmental arrest, and delayed puberty were seen. One chi
ld developed papillary thyroid carcinoma, 49 months post-BMT. Similar
neuropsychological testing decrements were also observed, Conclusion:
Our experience suggests that intensive chemoradiotherapy, even at a yo
ung age, does not cause severe, acute, or late toxicities but does res
ult in a small IQ decrement and the risk of second malignancy in child
ren with long-term follow-up.